ID
45914
Description
Principal Investigator: Mary-Claire King, University of Washington, Seattle, WA, USA MeSH: Schizophrenia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000959 The goal of this international collaborative project is to identify genes responsible for Schizophrenia in the Xhosa population of South Africa. The vast majority of the genetic basis for Schizophrenia has yet to be explained. We hypothesize that genes and pathways important to Schizophrenia will harbor different, severe disease-causing mutations in different affected individuals. Given the genetic diversity of African populations, we expect to find genes for Schizophrenia that have not yet emerged from studies of other populations. This project will also foster the development of gene discovery research for neuropsychiatric disorders in Africa. Our approach will identify genes important for the disorder in populations worldwide. These genes will stimulate future efforts to develop more effective treatment and prevention strategies.
Link
Keywords
Versions (1)
- 1/26/24 1/26/24 - Simon Heim
Copyright Holder
Mary-Claire King, University of Washington, Seattle, WA, USA
Uploaded on
January 26, 2024
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
dbGaP phs000959 Genomics of Schizophrenia in the South African Xhosa
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This subject phenotype table includes subject ID, case control status of the subject for schizophrenia, and sex.
- This sample attributes table contains sample IDs, body site, analyte type, tumor status, histological type, and name of the center which conducted sequencing.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This subject phenotype table includes subject ID, case control status of the subject for schizophrenia, and sex.
- This sample attributes table contains sample IDs, body site, analyte type, tumor status, histological type, and name of the center which conducted sequencing.
C0680251 (UMLS CUI [1,2])
C5772363 (UMLS CUI [1,2])
C5447420 (UMLS CUI [1,3])
C0036341 (UMLS CUI [1,4])
C0011900 (UMLS CUI [1,5])
C0220952 (UMLS CUI [1,6])
C5772363 (UMLS CUI [1,2])
C5447420 (UMLS CUI [1,3])
C0332296 (UMLS CUI [1,4])
C4534351 (UMLS CUI [1,5])